Trial NCT00562055

View at ClinicalTrials.gov 
Org. Study IDs: A6061060
Secondary IDs: A6061060

Last trial update was posted on 2019-04-16

MeSH Interventions

Atomoxetine Hydrochloride Reboxetine

MeSH Conditions

Attention Deficit Disorder with Hyperactivity Hyperkinesis

Other Conditions

Attention Deficit Hyperactivity Disorder

Stopping Reasons

This study was withdrawn due to business reasons.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID